| Nanoparticles and its biomedical applications in health and diseases: special focus on drug delivery N Zahin, R Anwar, D Tewari, MT Kabir, A Sajid, B Mathew, MS Uddin, ... Environmental Science and Pollution Research 27 (16), 19151-19168, 2020 | 272 | 2020 |
| Magnetic nanoparticles for hyperthermia in cancer treatment: an emerging tool J Jose, R Kumar, S Harilal, GE Mathew, DGT Parambi, A Prabhu, ... Environmental Science and Pollution Research 27, 19214-19225, 2020 | 211 | 2020 |
| Combination drug therapy for the management of Alzheimer’s disease MT Kabir, MS Uddin, AA Mamun, P Jeandet, L Aleya, RA Mansouri, ... International Journal of Molecular Sciences 21 (9), 3272, 2020 | 154 | 2020 |
| Advancements in nanotherapeutics for Alzheimer’s disease: current perspectives S Harilal, J Jose, DGT Parambi, R Kumar, GE Mathew, MS Uddin, H Kim, ... Journal of Pharmacy and Pharmacology 71 (9), 1370-1383, 2019 | 137 | 2019 |
| Emerging promise of sulforaphane-mediated Nrf2 signaling cascade against neurological disorders MS Uddin, A Al Mamun, M Jakaria, S Thangapandiyan, J Ahmad, ... Science of the Total Environment 707, 135624, 2020 | 134 | 2020 |
| Toxic tau: structural origins of tau aggregation in Alzheimer's disease A Al Mamun, MS Uddin, B Mathew, GM Ashraf Neural Regeneration Research 15 (8), 1417-1420, 2020 | 131 | 2020 |
| Melatonin in Alzheimer’s disease: a latent endogenous regulator of neurogenesis to mitigate Alzheimer’s neuropathology MF Hossain, MS Uddin, GMS Uddin, DM Sumsuzzman, MS Islam, ... Molecular Neurobiology 56, 8255-8276, 2019 | 130 | 2019 |
| Estrogen signaling in Alzheimer’s disease: molecular insights and therapeutic targets for Alzheimer’s dementia MS Uddin, MM Rahman, M Jakaria, MS Rahman, MS Hossain, A Islam, ... Molecular Neurobiology 57, 2654-2670, 2020 | 118 | 2020 |
| Emerging therapeutic potentials of dual‐acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases B Mathew, DGT Parambi, GE Mathew, MS Uddin, ST Inasu, H Kim, ... Archiv der Pharmazie 352 (11), 1900177, 2019 | 112 | 2019 |
| Nootropic and anti-Alzheimer’s actions of medicinal plants: molecular insight into therapeutic potential to alleviate Alzheimer’s neuropathology MS Uddin, A Al Mamun, MT Kabir, M Jakaria, B Mathew, GE Barreto, ... Molecular neurobiology 56, 4925-4944, 2019 | 112 | 2019 |
| Molecular insight into the therapeutic promise of flavonoids against Alzheimer’s disease MS Uddin, MT Kabir, K Niaz, P Jeandet, C Clément, B Mathew, A Rauf, ... Molecules 25 (6), 1267, 2020 | 111 | 2020 |
| Cholinesterase inhibitors for Alzheimer's disease: multitargeting strategy based on anti-Alzheimer's drugs repositioning MT Kabir, MS Uddin, M Begum, S Thangapandiyan, MS Rahman, L Aleya, ... Current Pharmaceutical Design 25 (33), 3519-3535, 2019 | 108 | 2019 |
| NMDA receptor antagonists: repositioning of memantine as a multitargeting agent for Alzheimer's therapy MT Kabir, MA Sufian, MS Uddin, M Begum, S Akhter, A Islam, B Mathew, ... Current Pharmaceutical Design 25 (33), 3506-3518, 2019 | 94 | 2019 |
| Revisiting the blood-brain barrier: A hard nut to crack in the transportation of drug molecules S Harilal, J Jose, R Kumar, MK Unnikrishnan, MS Uddin, GE Mathew, ... Brain research bulletin 160, 121-140, 2020 | 91 | 2020 |
| Development of fluorinated methoxylated chalcones as selective monoamine oxidase-B inhibitors: Synthesis, biochemistry and molecular docking studies B Mathew, GE Mathew, G Uçar, I Baysal, J Suresh, JK Vilapurathu, ... Bioorganic Chemistry 62, 22-29, 2015 | 89 | 2015 |
| Exploration of chlorinated thienyl chalcones: A new class of monoamine oxidase-B inhibitors B Mathew, A Haridas, G Uçar, I Baysal, AA Adeniyi, MES Soliman, M Joy, ... International journal of biological macromolecules 91, 680-695, 2016 | 77 | 2016 |
| Heteroaryl chalcones: Mini review about their therapeutic voyage B Mathew, J Suresh, S Anbazghagan, J Paulraj, GK Krishnan Biomedicine & Preventive Nutrition 4 (3), 451-458, 2014 | 77 | 2014 |
| Synthesis, biochemistry, and computational studies of brominated thienyl chalcones: A new class of reversible MAO‐B inhibitors B Mathew, A Haridas, G Uçar, I Baysal, M Joy, GE Mathew, ... ChemMedChem 11 (11), 1161-1171, 2016 | 75 | 2016 |
| Identification of Indole‐Based Chalcones: Discovery of a Potent, Selective, and Reversible Class of MAO‐B Inhibitors R Sasidharan, SL Manju, G Uçar, I Baysal, B Mathew Archiv der Pharmazie 349 (8), 627-637, 2016 | 73 | 2016 |
| Emerging signal regulating potential of small molecule biflavonoids to combat neuropathological insults of Alzheimer's disease MS Uddin, MT Kabir, D Tewari, B Mathew, L Aleya Science of the Total Environment 700, 134836, 2020 | 72 | 2020 |
Della Grace Thomas ParambiAssociate Professor , Jouf University在 ju.edu.sa 的电子邮件经过验证
